financetom
Business
financetom
/
Business
/
Paytm in talks to raise another $1 billion funding, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paytm in talks to raise another $1 billion funding, sources say
Nov 28, 2019 11:48 AM

Digital payments major Paytm is looking at raising another round of funding of $1 billion, and is in discussion with multiple investors, including former UK Prime Minister David Cameron, according to sources. Sources close to the development said the discussions are on and might take a few weeks to get finalised.

They added that the funds will be used to expand the merchant offerings across India to equip them with technology and various other services.

Paytm declined to comment, while a response from Cameron could not be elicited immediately.

Paytm had earlier this week announced a USD 1 billion (around Rs 7,173 crore) fund raise led by US-based asset management firm T Rowe Price. Existing investors Alibaba, Softbank and Discovery Capital had also participated in the funding round.

Interestingly, Paytm founder and Chief Executive Officer Vijay Shekhar Sharma tweeted a photograph of him and Cameron on Thursday.

"With so inspiring and savvy @David_Cameron in Singapore! Thanks Sir for your lesson on giving back to society and creating social impact with business," he added.

On Monday, Paytm had said it is planning to invest around USD 1.4 billion over the next three years to expand financial services.

Reports earlier this year had stated that Paytm, which is facing mounting losses, was looking at raising up to USD 2 billion in funding. The company has said it will look at a public listing only after 2021.

Paytm had raised USD 300 million from Warren Buffett's Berkshire Hathaway in September last year.

One97 Communications Ltd (OCL), the parent company of Paytm, had posted a loss of Rs 3,959.6 crore in 2018-19 as against Rs 1,490 crore a year ago, and its standalone revenue rose marginally to Rs 3,319 crore from Rs 3,229 crore in 2017-18, as per reports.

First Published:Nov 28, 2019 8:48 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Without astronauts, Boeing's Starliner returns to Earth
Without astronauts, Boeing's Starliner returns to Earth
Sep 6, 2024
* Starliner lands in New Mexico desert after troubled mission * NASA astronauts Wilmore and Williams to return on SpaceX vehicle in February 2025 * Boeing's ( BA ) Starliner program faces $1.6 billion in cost overruns since 2016 (Updates after Starliner returns to earth) By Joey Roulette WASHINGTON, Sept 6 (Reuters) - Boeing's ( BA ) Starliner spacecraft landed...
EXPLAINER-What is helium and why is it used in rockets?
EXPLAINER-What is helium and why is it used in rockets?
Sep 6, 2024
BENGALURU, Sept 7 (Reuters) - Two NASA astronauts aboard Boeing's ( BA ) Starliner will stay on the International Space Station for months because of a faulty propulsion system whose problems included helium leaks. Back on Earth, SpaceX's Polaris Dawn mission has been delayed because of helium issues on ground equipment. Boeing's ( BA ) Starliner spacecraft landed uncrewed in...
Lawmakers want US to address risks posed by Chinese agriculture drones
Lawmakers want US to address risks posed by Chinese agriculture drones
Sep 6, 2024
WASHINGTON (Reuters) -A dozen Republican U.S. lawmakers urged the Biden administration on Friday to address the use of Chinese-manufactured agriculture drones, saying their use on American farms poses national security risks. The House members, including Representatives Elise Stefanik, Ashley Hinson and John Moolenaar, who chairs a select committee on China, asked the Agriculture Department and Cybersecurity and Infrastructure Security Agency,...
Democrat to vote against bill restricting China's WuXi Biologics, BGI
Democrat to vote against bill restricting China's WuXi Biologics, BGI
Sep 6, 2024
(Reuters) - An influential Democratic U.S. congressman said on Friday that he will vote against legislation that would restrict business with China's WuXi Biologics ( WXIBF ), BGI and other biotech companies on national security grounds. Rep. Jim McGovern of Massachusetts, the ranking member on the House Rules committee, told Reuters he is trying to convince colleagues to join him...
Copyright 2023-2025 - www.financetom.com All Rights Reserved